Target intelligence / Profile preview

GARIN3 pseudogene 1 (GARIN3P1)

Target
GARIN3P1
Molecular classification
Other (pseudogene)
01

Overview

GARIN3 pseudogene 1 (GARIN3P1, also known as FAM71BP1) is annotated as a *pseudogene*, meaning it is a sequence in the human genome that resembles a protein-coding gene but generally contains mutations or deletions that prevent its translation into a functional protein[1]. It is located on chromosome 9 and is a member of the FAM71B pseudogene family. While some pseudogenes have been implicated in gene regulation through their RNA products—such as acting as competing endogenous RNAs, microRNA decoys, or regulatory elements affecting parental gene expression—there are no functionally characterized or disease associations reported for GARIN3P1 itself in the available literature[1][2]. It is not currently considered a therapeutic target, nor is it assigned a role in disease, drug interaction, gene expression regulation, or as a biomarker. Key points: - GARIN3P1 is a pseudogene with no evidence of coding or functional protein expression[1]. - Pseudogenes in general can sometimes have RNA-mediated regulatory effects, but specific evidence for GARIN3P1 is lacking in current databases and publications[2]. - It should not be used as a model drug target or assigned mechanisms of action, interacting drugs, biomarker status, or safety concerns in therapeutic contexts. If a regulatory or other function for GARIN3P1 is discovered in future genomics research, these attributes could be updated, but as of now it remains a non-target pseudogene[1].

Other names
FAM71BP1family with sequence similarity 71 member B pseudogene 1GARIN3P1
02

Biological functions

Other (no known coding function; see description)
03

Disease associations

Other (no known disease association specific to this pseudogene)

Beyond the preview

Go deeper on GARIN3 pseudogene 1 (GARIN3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GARIN3 pseudogene 1 (GARIN3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call